Compare ADMA Biologics Inc (ADMA) vs D R Horton Inc (DHI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs D R Horton Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while D R Horton Inc trades at $150.79 (market cap $42.18B). The key difference: D R Horton Inc is far larger — about 19× ADMA Biologics Inc's market cap, and D R Horton Inc pays a 1.19% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | DHI | |
|---|---|---|
Market Cap | $2.22B | $42.18B |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $184.04 |
52-Week Low | $7.60 | $132.53 |
Enterprise Value | $2.29B | $47.28B |
Dividend Yield | — | 1.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About D R Horton Inc
D.R. Horton is a leading homebuilder in the United States with operations in 98 markets across 31 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
Read more on DHI →
